ArticleYonago acta medica2026
A Questionnaire Survey on Human Papillomavirus Vaccination Among Hospital-Based Healthcare Professionals.
Article in Yonago acta medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although active human papillomavirus (HPV) vaccination recommendations resumed in Japan in 2022, vaccination rates remain low. Understanding hospital staff attitudes toward HPV vaccination may provide insights into improving vaccine uptake. Methods: An anonymous Google Form survey was conducted among Matsue City Hospital staff in August 2024. The questionnaire addressed knowledge and perceptions of cervical cancer and HPV vaccines, vaccination history, and future vaccination intentions. Respondents were classified as proactive or passive based on their family's vaccination intentions. Statistical analysis was performed using Fisher's exact test, with Results: Responses were received from 154 participants (response rate: 23.6%), with 88.3% of participants aged ≥ 27 years. While 89.0% and 82.4% reported being "well aware" or "aware" of cervical cancer and HPV vaccines, respectively, 40.3% were passive about family vaccination, and 36.4% expressed safety concerns. Acceptance of vaccine efficacy was significantly higher in the proactive group than in the passive group (96.7% vs. 59.7%, Conclusion: Approximately 40% of healthcare workers exhibited passive attitudes toward vaccination, and safety concerns significantly influenced their intentions. Improving accurate knowledge dissemination and addressing negative safety perceptions among hospital staff are crucial for increasing vaccination rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.